Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice

Julia Gamache, Kellie Benzow, Colleen Forster, Lisa Kemper, Chris Hlynialuk, Eva Furrow, Karen H Ashe, Michael D Koob

Research output: Contribution to journalArticle

Abstract

The tauopathy-like phenotype observed in the rTg4510 mouse line, in which human tauP301L expression specifically within the forebrain can be temporally controlled, has largely been attributed to high overexpression of mutant human tau in the forebrain region. Unexpectedly, we found that in a different mouse line with a targeted-insertion of the same transgene driven by the same tetracycline-TransActivator (tTA) allele, but with even higher overexpression of tauP301L than rTg4510, atrophy and tau histopathology are delayed, and a different behavioral profile is observed. This suggests that it is not overexpression of mutant human tau alone that contributes to the phenotype in rTg4510 mice. Furthermore we show that the tauopathy-like phenotype seen in rTg4510 requires a ~70-copy tau-transgene insertion in a 244 kb deletion in Fgf14, a ~7-copy tTA-transgene insertion in a 508 kb deletion that disrupts another five genes, in addition to high transgene overexpression. We propose that these additional effects need to be accounted for in any studies using rTg4510.

Original languageEnglish (US)
Article number2479
JournalNature communications
Volume10
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

Tauopathies
phenotype
Trans-Activators
Tetracycline
Transgenes
tetracyclines
mice
insertion
deletion
Phenotype
Prosencephalon
atrophy
Genes
genes
Atrophy
Alleles
profiles

Cite this

Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice. / Gamache, Julia; Benzow, Kellie; Forster, Colleen; Kemper, Lisa; Hlynialuk, Chris; Furrow, Eva; Ashe, Karen H; Koob, Michael D.

In: Nature communications, Vol. 10, No. 1, 2479, 01.12.2019.

Research output: Contribution to journalArticle

@article{178e30797f8a4efe88b892dacd4405f1,
title = "Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice",
abstract = "The tauopathy-like phenotype observed in the rTg4510 mouse line, in which human tauP301L expression specifically within the forebrain can be temporally controlled, has largely been attributed to high overexpression of mutant human tau in the forebrain region. Unexpectedly, we found that in a different mouse line with a targeted-insertion of the same transgene driven by the same tetracycline-TransActivator (tTA) allele, but with even higher overexpression of tauP301L than rTg4510, atrophy and tau histopathology are delayed, and a different behavioral profile is observed. This suggests that it is not overexpression of mutant human tau alone that contributes to the phenotype in rTg4510 mice. Furthermore we show that the tauopathy-like phenotype seen in rTg4510 requires a ~70-copy tau-transgene insertion in a 244 kb deletion in Fgf14, a ~7-copy tTA-transgene insertion in a 508 kb deletion that disrupts another five genes, in addition to high transgene overexpression. We propose that these additional effects need to be accounted for in any studies using rTg4510.",
author = "Julia Gamache and Kellie Benzow and Colleen Forster and Lisa Kemper and Chris Hlynialuk and Eva Furrow and Ashe, {Karen H} and Koob, {Michael D}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41467-019-10428-1",
language = "English (US)",
volume = "10",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice

AU - Gamache, Julia

AU - Benzow, Kellie

AU - Forster, Colleen

AU - Kemper, Lisa

AU - Hlynialuk, Chris

AU - Furrow, Eva

AU - Ashe, Karen H

AU - Koob, Michael D

PY - 2019/12/1

Y1 - 2019/12/1

N2 - The tauopathy-like phenotype observed in the rTg4510 mouse line, in which human tauP301L expression specifically within the forebrain can be temporally controlled, has largely been attributed to high overexpression of mutant human tau in the forebrain region. Unexpectedly, we found that in a different mouse line with a targeted-insertion of the same transgene driven by the same tetracycline-TransActivator (tTA) allele, but with even higher overexpression of tauP301L than rTg4510, atrophy and tau histopathology are delayed, and a different behavioral profile is observed. This suggests that it is not overexpression of mutant human tau alone that contributes to the phenotype in rTg4510 mice. Furthermore we show that the tauopathy-like phenotype seen in rTg4510 requires a ~70-copy tau-transgene insertion in a 244 kb deletion in Fgf14, a ~7-copy tTA-transgene insertion in a 508 kb deletion that disrupts another five genes, in addition to high transgene overexpression. We propose that these additional effects need to be accounted for in any studies using rTg4510.

AB - The tauopathy-like phenotype observed in the rTg4510 mouse line, in which human tauP301L expression specifically within the forebrain can be temporally controlled, has largely been attributed to high overexpression of mutant human tau in the forebrain region. Unexpectedly, we found that in a different mouse line with a targeted-insertion of the same transgene driven by the same tetracycline-TransActivator (tTA) allele, but with even higher overexpression of tauP301L than rTg4510, atrophy and tau histopathology are delayed, and a different behavioral profile is observed. This suggests that it is not overexpression of mutant human tau alone that contributes to the phenotype in rTg4510 mice. Furthermore we show that the tauopathy-like phenotype seen in rTg4510 requires a ~70-copy tau-transgene insertion in a 244 kb deletion in Fgf14, a ~7-copy tTA-transgene insertion in a 508 kb deletion that disrupts another five genes, in addition to high transgene overexpression. We propose that these additional effects need to be accounted for in any studies using rTg4510.

UR - http://www.scopus.com/inward/record.url?scp=85066955233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066955233&partnerID=8YFLogxK

U2 - 10.1038/s41467-019-10428-1

DO - 10.1038/s41467-019-10428-1

M3 - Article

VL - 10

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 2479

ER -